1. Alzheimer's dementia: current data review;Uzun;Coll. Antropol.,2011
2. Rivastigmine in the treatment of Alzheimer's disease: an update;Onor;Clin. Interv. Aging,2007
3. Novartis, Exelon® (Rivastigmine Tartrate) Capsules and Oral Solution, Prescribing Information, https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020823s016,021025s008lbl.pdf, Access date: 18 June 2018.
4. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease;Jann;Pharmacotherapy,2000
5. S.S. Lynch, Tolerance and Resistance to Drugs, MSD Manual, https://www.msdmanuals.com/home/drugs/factors-affecting-response-to-drugs/tolerance-and-resistance-to-drugs, Access date: 27 April 2018.